Figure 1:
Kaplan-Meier estimates for time to treatment failure (TTF) by treatment group
A: In all patients randomized (n=132)
B: in patients without primary resistance to Abiraterone Acetate (n=103).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.